Organogenesis Holdings (ORGO) Current Assets (2015 - 2026)

Organogenesis Holdings' Current Assets history runs 12 years deep, the most recent figure standing at $268.5 million for Q1 2026.

• On a quarterly basis, Current Assets changed 0.13% year-over-year to $268.5 million in Q1 2026; TTM through Mar 2026 was $268.5 million, a 0.13% change from a year earlier, with the FY2025 full-year figure at $362.2 million, up 26.67% from the prior year.
• Current Assets fell to $268.5 million in Q1 2026 per ORGO's latest filing, from $362.2 million in the prior quarter.
• Across five years, Current Assets topped out at $362.2 million in Q4 2025 and bottomed at $216.4 million in Q2 2023.
• The 5-year median for Current Assets is $231.5 million (2022), against an average of $248.9 million.
• Across the five-year window, Current Assets retreated 6.52% in 2023 and rose 27.06% in 2024, its largest moves.
• Year by year, Current Assets stood at $222.6 million in 2022, then rose by 1.09% to $225.0 million in 2023, then advanced by 27.06% to $285.9 million in 2024, then gained by 26.67% to $362.2 million in 2025, then retreated by 25.87% to $268.5 million in 2026.
• Per Business Quant, the three latest ORGO Current Assets figures stand at $268.5 million (Q1 2026), $362.2 million (Q4 2025), and $299.7 million (Q3 2025).